NextStep Robotics INC.

NextStep Robotics manufactures AMBLE, a wearable robotic device for foot drop gait training and neurorehabilitation. The device targets ankle impairments including foot drop from stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). AMBLE delivers graded robotic assistance with real-time biofeedback, adjusting assistance every step via proprietary algorithms. Key features include rapid donning (under 5 minutes), automatic robotic adjustments, objective progress tracking, and personalized therapy adaptation. Clinical evidence demonstrates 85% of patients discontinued assistive devices or ankle-foot orthoses (AFOs) after 6 weeks of AMBLE treatment. The company has secured $5.5M in NIH grant funding, including Phase 1 and Phase 2 trials. AMBLE is deployed in clinical rehabilitation settings, including University of Maryland Rehabilitation. NextStep positions itself as evidence-driven, with peer-reviewed publications supporting device efficacy. The device addresses a clinical need for affordable robotic rehabilitation solutions accessible to clinics of all sizes, with emphasis on high-intensity dosing, muscle strengthening, and clinician workflow efficiency.